Findings

What do systematic reviews say?

670 questions · 686 findings · 338 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 349 · 50.9%GRADE not reported 70 · 10.2%Very low 75 · 10.9%Low 75 · 10.9%Moderate 87 · 12.7%High 30 · 4.4%

Diacerein vs placebo

Quality of life Not measured · patients with osteoarthritis

The review found no eligible studies for this question.

1 finding from 1 review

Diacerein for osteoarthritis 2014 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ADJUNCTIVE TREATMENT ‐ NON‐SPECIFIC: SELEGILINE vs placebo

Quality of life not reported · patients with sexual dysfunction due to antipsychotic drug therapy

The review found no eligible studies for this question.

1 finding from 1 review

Management of sexual dysfunction due to antipsychotic drug therapy 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Sildenafil vs placebo

Quality of life not reported · patients with sexual dysfunction due to antipsychotic drug therapy

The review found no eligible studies for this question.

1 finding from 1 review

Management of sexual dysfunction due to antipsychotic drug therapy 2012 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings ‐ monotherapy: lumacaftor vs placebo

Quality of life ‐ total score · adults and children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings ‐ dual therapy: lumacaftor plus ivacaftor (twice daily) vs placebo

Quality of life ‐ total score · adults and children with cystic fibrosis

The review found no eligible studies for this question.

1 finding from 1 review

Corrector therapies (with or without potentiators) for people with cystic fibrosis with class II CFTR gene variants… 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Laigle‐Donadey 2019: dexamfetamine sulfate vs placebo

Health‐related quality of life European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC QLQ‐C30). Scale from: 0 to 100 (a higher score means a better outcome) · people with a primary brain tumour

1 finding from 1 review

Interventions for the management of fatigue in adults with a primary brain tumour 2022 · Cochrane Headline outcomes only
no estimate extracted
1 study · 41 participants
Very low

NSAIDs vs placebo

Quality of life: not reported · women with endometriosis

The review found no eligible studies for this question.

1 finding from 1 review

Nonsteroidal anti‐inflammatory drugs for pain in women with endometriosis 2017 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Kappa‐opioid agonists vs placebo

Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Ondansetron vs placebo

Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ GABA‐analogues vs placebo

Quality of life ‐ not measured · health problem or population

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Montelukast vs placebo

Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Omega‐3 vs placebo

Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Zinc sulphate vs placebo

Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Cromolyn sodium vs placebo

Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Topical capsaicin vs placebo

Quality of life ‐ not measured · patients with chronic kidney disease (CKD) pruritus

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

naltrexone vs placebo

Quality of life ‐ not measured · participants with cholestatic pruritus (CP)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Rifampin/rifampicin vs placebo

Quality of life ‐ not measured · participants with cholestatic pruritus (CP)

The review found no eligible studies for this question.

1 finding from 1 review

Pharmacological interventions for pruritus in adult palliative care patients 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Antibiotics vs placebo or no intervention

Quality of life ‐ not reported · farmworkers, soldiers, and people in endemic areas

The review found no eligible studies for this question.

1 finding from 1 review

Antibiotic prophylaxis for leptospirosis 2024 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Summary of findings table ‐ Recombinant activated factor VII vs placebo/open control

Quality of life ‐ not reported · adults with acute spontaneous intracerebral haemorrhage

The review found no eligible studies for this question.

1 finding from 1 review

Haemostatic therapies for stroke due to acute, spontaneous intracerebral haemorrhage 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Prostaglandin vs placebo or usual care

Health‐related quality of life · adult patients after liver transplantation.

The review found no eligible studies for this question.

1 finding from 1 review

Prostaglandins for adult liver transplanted recipients 2023 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found